Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability

This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian governm...

Descripción completa

Detalles Bibliográficos
Autor principal: Kotwani, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Psychiatrists 2012
Materias:
Thematic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735055/
https://www.ncbi.nlm.nih.gov/pubmed/31508114
_version_ 1783450275857563648
author Kotwani, Anita
author_facet Kotwani, Anita
author_sort Kotwani, Anita
collection PubMed
description This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian government’s pricing regulations and then enumerates recommendations for reform.
format Online
Article
Text
id pubmed-6735055
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Royal College of Psychiatrists
record_format MEDLINE/PubMed
spelling pubmed-67350552019-09-10 Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability Kotwani, Anita Int Psychiatry Thematic Paper This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian government’s pricing regulations and then enumerates recommendations for reform. The Royal College of Psychiatrists 2012-05-01 /pmc/articles/PMC6735055/ /pubmed/31508114 Text en © 2012 The Royal College of Psychiatrists http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Thematic Paper
Kotwani, Anita
Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
title Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
title_full Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
title_fullStr Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
title_full_unstemmed Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
title_short Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
title_sort psychiatric medicines in india: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
topic Thematic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735055/
https://www.ncbi.nlm.nih.gov/pubmed/31508114
work_keys_str_mv AT kotwanianita psychiatricmedicinesinindiawhypublichealthcarefacilitiesandathrivinggenericsindustrycannotassureaccessandaffordability

Ejemplares similares